Back
CRISPR Therapeutics AG Stock Price Chart
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
49
CRSP
CRISPR Therapeutics AG
Last Price:
$41.86
Seasonality Move:
7.92%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.97 | Buy |
| 20-day SMA: | 37.59 | Buy |
| 50-day SMA: | 36.86 | Buy |
| 200-day SMA: | 43.4 | Sell |
| 8-day EMA: | 38.61 | Buy |
| 20-day EMA: | 37.68 | Buy |
| 50-day EMA: | 33.29 | Buy |
| 200-day EMA: | 15.77 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.07 | Buy |
| Relative Strength Index (14 RSI): | 65.18 | Buy |
| Chaikin Money Flow: | 3023115 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.59 - 38.91) | Buy |
| Bollinger Bands (100): | (35.79 - 43.79) | Buy |
CRISPR Therapeutics AG Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 41.86 while CRSP 8-day simple moving average is 37.97, which is a Buy signal.
-
The stock price of CRSP is 41.86 while CRISPR Therapeutics AG 20-day SMA is 37.59, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 36.86 while CRSP share price is 41.86, making it a Buy technically.
-
CRSP stock price is 41.86 and CRISPR Therapeutics AG 200-day simple moving average is 43.40, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
49
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $41.86. The Score for CRSP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.6B
Price in USD:
41.86
Share Volume:
4.7M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
67.88
52-Week Low:
30.04
Sell
49
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 41.86 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 41.86 while CRSP 8-day exponential moving average is 38.61, which is a Buy signal.
-
The stock price of CRSP is 41.86 while CRISPR Therapeutics AG 20-day EMA is 37.68, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 33.29 while CRSP share price is 41.86, making it a Buy technically.
-
CRSP stock price is 41.86 and CRISPR Therapeutics AG 200-day simple moving average is 15.77, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.32 per share, and an increase next year of $1.02 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 1.07, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 65.18, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (35.59 - 38.91), which suggest CRISPR Therapeutics AG is a Buy
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (35.79 - 43.79), which suggest CRISPR Therapeutics AG is a Buy
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.